← Company Index
Medical DevicesKOSPI 00309012 approvals7 trials

DAEWOONG CO.,LTD

Official website

Founded in 1961 and listed in 1973, Daewoong is a KOSPI holding company managing 35 subsidiaries including Daewoong Pharmaceutical.

As of 2026-10-11, DAEWOONG CO.,LTD has 12 Korean MFDS device approvals, 21 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Established in 1961 and listed on the KOSPI in 1973, Daewoong Co., Ltd. is a holding company whose subsidiaries include Daewoong Pharmaceutical, Daewoong Bio, and HanAll Biopharma. Its core businesses are investment activities and management services, and as of December 31, 2025 it held a total of 35 subsidiaries, including Daewoong Pharmaceutical, Daewoong Bio, and HanAll Biopharma. Operating revenue consists of service fees, royalties, and dividends collected from subsidiaries and other invested companies; in its 66th fiscal term (2025), consolidated revenue reached KRW 2.0684 trillion (up 6.8% year-on-year), operating profit was KRW 261.8 billion (down 7.1%), and net income was KRW 227.9 billion (up 231.0%).

Regulatory approvals

data.go.kr

12 Korean MFDS device approvals · 2002–2005

  • MFDS의료용물질생성기Revoked2005-04-09
    Product approval · Class 2제허 05-255 호
  • MFDS개인용온열기Revoked2005-01-25
    Product approval · Class 2제허 05-69 호
  • MFDS의료용진동기Revoked2004-12-24
    Product approval · Class 2제허 04-1280 호
  • MFDS의료용진동기Revoked2004-10-20
    Product approval · Class 2제허 04-1074 호
  • MFDS개인용조합자극기Revoked2004-08-17
    Product approval · Class 2제허 04-854 호
  • MFDS개인용조합자극기Revoked2003-06-02
    Product approval · Class 2제허 03-467 호
  • MFDS개인용온열기Revoked2002-12-09
    Product approval · Class 2제허 02-943 호
  • MFDS개인용조합자극기Revoked2002-11-22
    Product approval · Class 2제허 02-906 호
  • MFDS의료용진동기Revoked2002-09-02
    Product approval · Class 2제허 02-715 호
  • MFDS개인용조합자극기Revoked2002-08-27
    Product approval · Class 2제허 02-696 호
  • MFDS의료용진동기Revoked2002-06-28
    Product approval · Class 2제허 02-531 호
  • MFDS개인용조합자극기Revoked2002-03-20
    Product approval · Class 2제허 02-232 호

Clinical trials

data.go.kr

7 MFDS clinical trial authorisations · 2012–2017 (Bioequivalence 5 · Phase 1 1 · Phase 3 1)

  • Phase 1메트포르민염산염, 아토르바스타틴칼슘2017-02-07

    1 trial site

  • Phase 3메트포르민염산염, 아토르바스타틴칼슘2015-03-19

    36 trial sites

  • BioequivalenceDWJ1333-1정2014-05-01

    2 trial sites

  • Bioequivalence대웅올메사탄플러스정20/12.5밀리그램2013-12-10

    2 trial sites

  • BioequivalenceDWJ1334정 20밀리그램(올메사탄메독소밀)2013-12-03

    2 trial sites

  • BioequivalenceDWJ1333정2013-09-04
  • Bioequivalence대웅콜린알포세레이트연질캡슐 400mg2012-07-31

    2 trial sites

Global clinical trials

ClinicalTrials.gov · sponsor-matched

Key disclosures

KRX KIND via OpenDART
Show 17 more events

Publications

PubMed · affiliation-matched
Show 11 more publications

Patents

KIPRIS · applicant-matched
Show 329 more patents

AI reads

MAA server logs · IP-verified
45
Times AI engines pulled DAEWOONG CO.,LTD's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

2
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

43
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

10
live 0
Last 7 days
38
live 2
Last 30 days
45
live 2
All time
  • OpenAIChatGPT-Userlive2
  • OpenAIOAI-SearchBot37
  • PerplexityPerplexityBot2
  • GoogleGoogleOther2
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for DAEWOONG CO.,LTD and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · products · R&D. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Alpha AI Co.,Ltd.2 shared

Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.

DongBang Medical Co., Ltd.1 shared

KOSDAQ-listed medical device maker producing disposable acupuncture needles, cupping cups, and hyaluronic acid dermal fillers.

Dynamic solution Co.,Ltd.1 shared

Founded in 2010 and KOSDAQ-listed in 2018, Dynamic Solution makes AI/IoT-based rehabilitation devices like the Rapael Smart Glove.

INTEROJO CO. LTD.100

Interojo, founded 2000 and KOSDAQ-listed 2010, manufactures contact lenses under its Clalen brand domestically and via OEM/ODM overseas.

MITECH CO.,LTD.100

MITECH CO.,LTD., founded in 1991 and listed on KOSDAQ in 2018, makes non-vascular stents and distributes Fujifilm endoscopy equipment.

JETEMA Co.,Ltd.90

Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.

Corentec Co., Ltd.85

Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.

NanoenTek,Inc.85

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

SEJONG MEDICAL Co.Ltd.,85

Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.

REMEDI Inc.85

Founded in 2012 and listed on KOSDAQ in 2026, REMEDI develops portable X-ray imaging devices based on its low-dose, miniaturized X-ray technology.

Laseroptek Co., Ltd.85

KOSDAQ-listed medical device company developing the LOTUS and HELIOS laser aesthetic devices and the PALLAS vitiligo treatment device.

AIOBIO Co., Ltd.85

Develops quantitative fluorescence biomarker technology for oral disease diagnostic devices.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition